Trials / Recruiting
RecruitingNCT05597410
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,418 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
The goal of this cohort study is to estimate the incidence of AD in the first-degree relatives of patients with AD. The main questions it aims to answer are: * cognitive changes of subjects at high risk of AD as ageing; * environmental and behavioral factors affecting AD incidence.
Detailed description
This study is a prospective cohort study focusing on the first-degree relatives of patients with Alzheimer's disease (AD). Multiple methods including the neuropsychiatric assessment battery, magnetic resonance imaging (MRI) and fluid biomarkers (blood and urine) are used to estimate the longitudinal changes of the participants at high risk of AD. Besides, a structured questionnaire is designed to investigate how environmental, behavioral and other factors influence the incidence of AD. This study is of great significance in establishing novel guidelines for the prevention and treatment of dementia suitable for Chinese population, and for clinicians to predict the risk of AD in first-degree relatives.
Conditions
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2029-03-01
- Completion
- 2030-03-01
- First posted
- 2022-10-28
- Last updated
- 2022-10-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05597410. Inclusion in this directory is not an endorsement.